POTASSIUM CHLORIDE0.30% , DEXTROSE 5% , NS0.45% 500 ML BOTTLE_ALRAZI

Product Details

This solution, manufactured by Alrazi Pharmaceutical Industries, is an intravenous electrolyte and dextrose solution. It combines Potassium Chloride 0.30%, Dextrose 5%, and 0.45% Sodium Chloride in a 500 mL bottle, designed for intravenous administration. It is used to replenish fluids, provide essential electrolytes (sodium and potassium), and supply a source of calories from dextrose (glucose) for patients who are unable to take fluids or nutrition orally, or who require specific electrolyte corrections.

Benefits of Use

• Fluid Restoration: Effectively rehydrates patients suffering from dehydration or fluid loss.
• Electrolyte Balance: Provides critical electrolytes, sodium and potassium, essential for normal cellular function, nerve impulse transmission, and muscle contraction.
• Energy Source: Dextrose (glucose) supplies necessary calories, helping to prevent ketosis and provide metabolic energy.
• Hypokalemia Treatment: Addresses and prevents potassium deficiency (hypokalemia) due to various clinical conditions.
• Maintenance Therapy: Suitable for daily maintenance of fluid, electrolyte, and caloric needs in hospitalized patients.

How to Use

This medication is for intravenous use only and must be administered by a qualified healthcare professional. The dosage and rate of administration are determined by the patient's age, weight, clinical condition, and metabolic needs.

1. Ensure proper aseptic technique is followed during preparation and administration.
2. Inspect the solution for clarity and the container for any damage or leaks before use.
3. Administer intravenously via a suitable catheter or needle into a peripheral or central vein.
4. Monitor the patient's fluid balance, electrolyte levels, and renal function regularly throughout treatment.
5. Adjust the infusion rate as per physician's orders based on clinical response and laboratory findings.

Caution & Warnings

• For intravenous administration only. Do not inject intramuscularly or subcutaneously.
• Not for direct injection. Must be administered as an infusion.
• Monitor serum electrolyte concentrations (especially potassium and sodium) closely to avoid imbalances.
• Exercise caution in patients with cardiac disease, renal impairment, or conditions predisposing to hyperkalemia (e.g., severe burns, adrenal insufficiency).
• Rapid infusion can lead to fluid overload, cardiac arrhythmia, or hyperkalemia. Administer slowly as prescribed.
• Discontinue administration immediately if adverse reactions such as fever, infection at the injection site, or local pain occur.
• Do not use if the solution is discolored, cloudy, or if the bottle is damaged.
• Consult a healthcare professional regarding potential drug interactions with other medications.

Ingredients

• Potassium Chloride 0.30%
• Dextrose (Glucose) 5%
• Sodium Chloride 0.45%
• Water for Injection

Product Details

• Strength: Potassium Chloride 0.30%, Dextrose 5%, Sodium Chloride 0.45%
• Volume: 500 mL
• Form: Solution for infusion
• Packaging: Bottle
• Manufacturer: Alrazi Pharmaceutical Industries